Abbott Laboratories has declared a quarterly dividend of $0.63 per share, extending its uninterrupted dividend payment streak to 409 consecutive quarters spanning over a century. The payment is scheduled for May 15, 2026, to shareholders registered as of April 15, 2026, underscoring the healthcare company's commitment to returning capital to investors.
The declaration marks another milestone in Abbott's distinguished dividend history, which traces back to 1924. The company has achieved 54 consecutive years of dividend increases, a distinction that qualifies it for inclusion in the S&P 500 Dividend Aristocrats Index—an elite group of companies demonstrating sustained shareholder value creation through dividend growth.
Abbott's dividend longevity reflects the stability of its business model across multiple market cycles and economic conditions. The company's track record positions it among a select group of U.S. corporations that have maintained uninterrupted dividend payments throughout periods of significant economic and market disruption.